Mutasi Onkogen dan Tumor Suppressor Gen pada Xeroderma Pigmentosum
Downloads
Digiovanna JJ, Kraemer KH. Shining a light on xeroderma pigmentosum. J Invest Dermatol 2012;132:785-96.
PallerA, Mancini A. Hurwitz Clinical Pediatric Dermatoloy. 5th ed. Brisbane; Elsevier, 2016.
Adisty R. Studi retrospektif: Insidensi dan penatalaksanaan genodermatosis di IRNA Kulit dan Kelamin RSUD DR. Soetomo Surabaya tahun 2010-2014. Unpublished
Burnd T, Breathnach S, Cox N, Griffiths C: Rook’s textbook dermatology. 8th ed. Oxford: Willey Blackwell; 2010.
Lehmann AR, McgibbonD, Stefanini M. xeroderma pigmentosum. Orphanet J Rare Dis 2011;6:2-6.
Weedon D. Weedon’s skin pathology.3rd ed. Brisbane; Elsevier, 2010.
Fromm LK, James DW. Xeroderma pigmentosum. (cited 2016 July 5). Available from URL: http://emedicine.medscape.com/ article/1119902-overview.
Emmert S, Schubert S, Lehmann J. Xeroderma pigmentosum: diagnostic procedures, interdisciplinary patient care, and novel therapeutic approaches. JDDG 2014;1210:867-72.
Sarasin A, Grosjesan LD. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutation Research 2005;571:43-56.
Senthi M, Lehmann AR, Fassihi H. Xeroderma pigmentosum: A multidisciplinary approach. EMJ Dermatol 2013;1:54-63.
Dupuy A, Sarasin A. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease. Mutation Research 2014;27:1-7.
Lavu S, Srivastava M, Srivastava KS. Analysis of the tumor suppressor gen p53 in xeroderma pigmentosum fibroblast. Cancer Letter 1994;85: 9-12.
PallerA, Mancini A. Hurwitz Clinical Pediatric Dermatoloy. 5th ed. Brisbane; Elsevier, 2016.
Dumaz N, Drougard X, Sarasin A, Grosjesjean LD. Spesific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci 1993;90:10529-33.
Rady P, Scinicariello F, Wagner R, Tyring K. p53 mutations in basal cell carcinomas. Cancer Res 1992;52:3804-6.
Sato M, Nishigori C, Lu Y, Yagi T. far less frequent mutations in ras gene than in the p53 gene in skin tumor of xeroderma pigmentosum patients. Mol Carcinog 1994:11;98-105.
Soufir N, Grosjean LD, Salmoniere P. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. National Cancer Institute 2000:92;1841-7.
Ping XL, Ratner Dm, Zhang H, Zhang JM. PTCH mutations in squamous cell carcinoma of the skin. J Invest Dermatol 2000:116;614-6.
Grosjean LD. Xeroderma pigmentosum and skin cancer. Dalam: Ahmad Si, Hanaoka F, editor. Molecular mechanism of xeroderma pigmentosum. New York:Springer;2008.h.637-46.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
